Product Description
Spnib 50 mg Tablet may cause certain side effects, such as skin rash, fatigue, headache, musculoskeletal pain, decreased platelet count, nausea, vomiting, diarrhea, abdominal pain, dizziness, GI bleeding, muscle inflammation, myalgia, and difficulty breathing. These side effects do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor. Spnib 50 mg Tablet should be taken as advised by your doctor. Do not take more than the recommended dose of medicine. Your doctor will decide the dose of Spnib 50 mg Tablet based on the severity of your condition.
Spnib 50 mg Tablet should be avoided if you are allergic to it or any other components present in it. Before taking Spnib 50 mg Tablet , caution should be exercised if you have/had liver/kidney disease, gastrointestinal disorders, cardiac problems, and myelosuppression as may cause serious side effects or worsen such conditions. This medicine is known to cause embryo-fetal toxicity. Hence, inform your doctor if you are pregnant or are planning to become pregnant before starting the treatment with Spnib 50 mg Tablet . Breastfeeding should be discontinued in nursing mothers during the treatment.
Expertly Formulated for Targeted SupportSpnib 50 Mg Tablets are crafted using Nintedanib, a well-established active ingredient for combating idiopathic pulmonary fibrosis and select forms of NSCLC. Delivered as easy-to-swallow oral tablets, this prescription medication is formulated for adult patients seeking advanced medical support for their condition. Its trusted allopathic origin ensures a reliable and consistent approach to disease management.
Comprehensive Packaging and Storage GuidelinesEach box of Spnib 50 Mg Tablets contains 30 tablets, with each strip providing 10 tablets for convenience. The tablets should be safeguarded from both light and moisture and stored in a cool, dry environment below 30C for optimal preservation. The medication maintains its quality and potency for 24 months from its manufacturing date, supporting proper inventory practices for healthcare providers and patients alike.
FAQ's of Spnib 50 Mg Tablets:
Q: How should Spnib 50 Mg Tablets be taken for best results?
A: Spnib 50 Mg Tablets should be taken with food or as otherwise instructed by your healthcare provider. Always follow your doctor's dosage recommendations and never exceed the prescribed amount.
Q: What is the main function of Spnib 50 Mg Tablets?
A: The tablets serve as an anti-cancer and anti-fibrotic agent, primarily prescribed for adult patients with idiopathic pulmonary fibrosis and certain types of non-small cell lung cancer.
Q: When should this medication be used?
A: Spnib 50 Mg Tablets are used upon the diagnosis of conditions such as idiopathic pulmonary fibrosis or specific forms of NSCLC, as determined by a qualified physician.
Q: Where should Spnib 50 Mg Tablets be stored?
A: The medicine should be kept in a cool, dry place below 30C, and protected from both light and moisture to maintain its efficacy.
Q: What are the benefits of using Spnib 50 Mg Tablets?
A: Spnib 50 Mg Tablets help slow disease progression in idiopathic pulmonary fibrosis and improve patient outcomes in certain types of non-small cell lung cancer by inhibiting processes that contribute to fibrosis and tumor growth.
Q: Who is eligible to take Spnib 50 Mg Tablets?
A: This prescription medication is suitable for adults diagnosed with idiopathic pulmonary fibrosis or selected types of non-small cell lung cancer, as assessed by a healthcare professional.
Q: What is the shelf life and packaging size of Spnib 50 Mg Tablets?
A: Spnib 50 Mg Tablets have a shelf life of 24 months from the date of manufacture and are typically packaged with 30 tablets per box, divided among three strips of 10 tablets each.